Within bioanalysis, there are differences with the execution of small and large molecule projects. Now with the increase of larger and more complex substances, drug developers are faced with new opportunities to evaluate and challenges to address.                                                                                                                                                                     

In this white paper, learn about:

• Bioanalysis by molecular size

• Advances in mass spectrometry

• Visualization and quantification of drug distribution